Integrative multi-omics analysis identifies AEBP1 and EFEMP2 as key regulators of immune heterogeneity and therapeutic response in glioblastoma.

Discov Oncol · 2025 · PMC12484469 · PMID 41026376

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

an increasing trendno p-value reported

The results showed that AEBP1 and EFEMP2 were significantly upregulated in GBM tissues (p < 0.05), whereas RPL39L and GALNT12 exhibited an increasing trend but did not reach statistical significance (p > 0.05).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.